OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins

Trends in Molecular Medicine

Volumn 14, Issue 5, 2008, Pages 219-227

  Maiese, Kenneth ^a   Chong, Zhao Zhong ^a   Shang, Yan Chen ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXO;

AGING; APOPTOSIS; CARCINOGENESIS; CELL METABOLISM; DIABETES MELLITUS; DISABILITY; HUMAN; IMMUNOPATHOLOGY; INFERTILITY; LONGEVITY; NEOPLASM; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATIENT CARE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STRUCTURE ACTIVITY RELATION;

ANIMALS; APOPTOSIS; CELL MOVEMENT; DRUG DESIGN; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; OXIDATIVE STRESS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 42749086593     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2008.03.002     Document Type: Review

References (90)

1. Chong Z.Z., et al. Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog. Neurobiol. 75 (2005) 207-246
2. Maiese K., et al. Sly as a FOXO: new paths with Forkhead signaling in the brain. Curr. Neurovasc. Res. 4 (2007) 295-302
3. Hoekman M.F., et al. Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain. Gene Expr. Patterns 6 (2006) 134-140
4. Jagani Z., et al. FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis. Biochim. Biophys. Acta 1785 (2008) 63-84
5. Myatt S.S., and Lam E.W. The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer 7 (2007) 847-859
6. van der Horst A., and Burgering B.M. Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol. 8 (2007) 440-450
7. Wijchers P.J., et al. In control of biology: of mice, men and Foxes. Biochem. J. 397 (2006) 233-246
8. Biggs III W.H., et al. Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse. Mamm. Genome 12 (2001) 416-425
9. Huang H., and Tindall D.J. Dynamic FoxO transcription factors. J. Cell Sci. 120 (2007) 2479-2487
10. Van Der Heide L.P., et al. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem. J. 380 (2004) 297-309
11. Furuyama T., et al. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J. 349 (2000) 629-634
12. Hosaka T., et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2975-2980
13. Castrillon D.H., et al. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301 (2003) 215-218
14. Liu L., et al. Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a. Development 134 (2007) 199-209
15. Lin L., et al. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21 (2004) 203-213
16. Jonsson H., et al. Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat. Med. 11 (2005) 666-671
17. Tothova Z., et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128 (2007) 325-339
18. Miyamoto K., et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1 (2007) 101-112
19. Mahmud D.L., et al. Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells. Oncogene 21 (2002) 1556-1562
20. Maiese K., et al. New avenues of exploration for erythropoietin. J. Am. Med. Assoc. 293 (2005) 90-95
21. Bakker W.J., et al. Differential regulation of Foxo3a target genes in erythropoiesis. Mol. Cell. Biol. 27 (2007) 3839-3854
22. Srinivasan S., et al. Enteric neuroblasts require the phosphatidylinositol 3-kinase/Akt/Forkhead pathway for GDNF-stimulated survival. Mol. Cell. Neurosci. 29 (2005) 107-119
23. Maiese K., et al. Mechanisitic insights into diabetes mellitus and oxidative stress. Curr. Med. Chem. 14 (2007) 1729-1738
24. Maiese K., et al. Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr. Neurovasc. Res. 4 (2007) 63-71
25. Fallarino F., et al. CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. J. Exp. Med. 200 (2004) 1051-1062
26. Matsumoto M., et al. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor foxo1 in liver. Cell Metab. 6 (2007) 208-216
27. Kato M., et al. Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J. Am. Soc. Nephrol. 17 (2006) 3325-3335
28. Chong Z.Z., et al. Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling. Curr. Neurovasc. Res. 4 (2007) 194-204
29. Anitha M., et al. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J. Clin. Invest. 116 (2006) 344-356
30. Kwon H.S., et al. Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors. Diabetes 53 (2004) 899-910
31. Kino T., et al. HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infected patients. Diabetes 54 (2005) 23-31
32. Maiese K., and Chong Z.Z. Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol. Sci. 24 (2003) 228-232
33. Furuyama T., et al. Effects of aging and caloric restriction on the gene expression of Foxo1, 3, and 4 (FKHR, FKHRL1, and AFX) in the rat skeletal muscles. Microsc. Res. Tech. 59 (2002) 331-334
34. Puig O., and Tjian R. Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev. 19 (2005) 2435-2446
35. Kamei Y., et al. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 279 (2004) 41114-41123
36. Chong Z.Z., et al. Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr. Neurovasc. Res. 2 (2005) 387-399
37. Chong Z.Z., et al. Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways. Cell. Signal. 19 (2007) 1150-1162
38. Smith W.W., et al. Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity. J. Cell Biol. 169 (2005) 331-339
39. Essers M.A., et al. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 308 (2005) 1181-1184
40. Nakamura T., and Sakamoto K. Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis. Mol. Cell. Endocrinol. 281 (2008) 47-55
41. Won C.K., et al. Estradiol prevents the focal cerebral ischemic injury-induced decrease of forkhead transcription factors phosphorylation. Neurosci. Lett. 398 (2006) 39-43
42. Chong Z.Z., et al. Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-Catenin during oxidative stress. Curr. Neurovasc. Res. 3 (2006) 107-117
43. Chong Z.Z., et al. The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential. J. Cereb. Blood Flow Metab. 24 (2004) 728-743
44. Chong Z.Z., and Maiese K. Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity. Br. J. Pharmacol. 150 (2007) 839-850
45. Zheng W.H., et al. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J. Neurochem. 80 (2002) 1049-1061
46. Barthélémy C., et al. Foxo3a induces motoneuron death through the Fas pathway in cooperation with JNK. BMC Neurosci. 5 (2004) 48
47. Obexer P., et al. FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ. 14 (2007) 534-547
48. You H., et al. Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 9051-9056
49. Furukawa-Hibi Y., et al. FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J. Biol. Chem. 277 (2002) 26729-26732
50. Delpuech O., et al. Induction of Mxi1-SR{alpha} by FOXO3a contributes to repression of Myc-dependent gene expression. Mol. Cell. Biol. 27 (2007) 4917-4930
51. Kikuchi S., et al. Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Sci. 98 (2007) 1949-1958
52. Jacobsen E.A., et al. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene. J. Immunol. 176 (2006) 6831-6838
53. Brunet A., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 (2004) 2011-2015
54. Kang J.Q., et al. Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. Mol. Pharmacol. 64 (2003) 557-569
55. Li F., et al. Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB. Curr. Neurovasc. Res. 3 (2006) 187-201
56. Sela U., et al. The negative regulators Foxj1 and Foxo3a are up-regulated by a peptide that inhibits systemic lupus erythematosus-associated T cell responses. Eur. J. Immunol. 36 (2006) 2971-2980
57. Hur E.M., et al. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8 (2007) 74-83
58. Li F., et al. Cell life versus cell longevity: the mysteries surrounding the NAD(+) precursor nicotinamide. Curr. Med. Chem. 13 (2006) 883-895
59. Tissenbaum H.A., and Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410 (2001) 227-230
60. Nemoto S., et al. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306 (2004) 2105-2108
61. Motta M.C., et al. Mammalian SIRT1 represses forkhead transcription factors. Cell 116 (2004) 551-563
62. Kobayashi Y., et al. SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int. J. Mol. Med. 16 (2005) 237-243
63. van der Horst A., et al. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J. Biol. Chem. 279 (2004) 28873-28879
64. Kyoung Kim H., et al. Down-regulation of a forkhead transcription factor, FOXO3a, accelerates cellular senescence in human dermal fibroblasts. J. Gerontol. A Biol. Sci. Med. Sci. 60 (2005) 4-9
65. Ferrara N., et al. Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res. 11 (2008) 139-150
66. Li M., et al. Down-regulation of manganese-superoxide dismutase through phosphorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats. J. Biol. Chem. 281 (2006) 40429-40439
67. Miyauchi H., et al. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 23 (2004) 212-220
68. Paik J.H., et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128 (2007) 309-323
69. Sunters A., et al. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. Cancer Res. 66 (2006) 212-220
70. Eddy S.F., et al. Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. Cancer Res. 67 (2007) 9018-9023
71. Modur V., et al. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J. Biol. Chem. 277 (2002) 47928-47937
72. Lynch R.L., et al. The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation. Mol. Cancer Res. 3 (2005) 163-169
73. Li Y., et al. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3, 3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J. Biol. Chem. 282 (2007) 21542-21550
74. Yang L., et al. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells. J. Biol. Chem. 280 (2005) 33558-33565
75. Ticchioni M., et al. Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene 26 (2007) 7081-7091
76. Munoz-Fontela C., et al. Latent protein LANA2 from Kaposi's sarcoma-associated herpesvirus interacts with 14-3-3 proteins and inhibits FOXO3a transcription factor. J. Virol. 81 (2007) 1511-1516
77. Arimoto-Ishida E., et al. Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin. Endocrinology 145 (2004) 2014-2022
78. Chong Z.Z., et al. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106 (2002) 2973-2979
79. Chong Z.Z., et al. Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. Histol. Histopathol. 20 (2005) 299-315
80. Hu M.C., et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117 (2004) 225-237
81. Leong M.L., et al. Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J. Biol. Chem. 278 (2003) 5871-5882
82. Lehtinen M.K., et al. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125 (2006) 987-1001
83. Watkins W.J., et al. Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure. Fertil. Steril. 86 (2006) 1518-1521
84. Ludikhuize J., et al. Inhibition of forkhead box class O family member transcription factors in rheumatoid synovial tissue. Arthritis Rheum. 56 (2007) 2180-2191
85. Kuo C.C., and Lin S.C. Altered FOXO1 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients. Mol. Med. 13 (2007) 561-566
86. Kim J.R., et al. Polymorphisms in FOXO gene family and association analysis with BMI. Obesity (Silver Spring). 14 (2006) 188-193
87. Kuningas M., et al. Haplotypes in the human Foxo1a and Foxo3a genes; impact on disease and mortality at old age. Eur. J. Hum. Genet. 15 (2007) 294-301
88. Bosque A., et al. The induction of Bim expression in human T-cell blasts is dependent on nonapoptotic Fas/CD95 signaling. Blood 109 (2007) 1627-1635
89. Jin G.S., et al. Expression and intracellular localization of FKHRL1 in mammary gland neoplasms. Acta Med. Okayama 58 (2004) 197-205
90. Gomez-Gutierrez J.G., et al. Adenovirus-mediated gene transfer of FKHRL1 triple mutant efficiently induces apoptosis in melanoma cells. Cancer Biol. Ther. 5 (2006) 875-883